TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 277 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $188,177 | -3.6% | 12,164 | -2.1% | 0.00% | 0.0% |
| Q2 2023 | $195,165 | -38.3% | 12,423 | -35.3% | 0.00% | -33.3% |
| Q1 2023 | $316,484 | -44.7% | 19,204 | -47.7% | 0.00% | -40.0% |
| Q4 2022 | $572,458 | -99.8% | 36,696 | -31.2% | 0.01% | +25.0% |
| Q3 2022 | $346,346,000 | +95050.0% | 53,310 | +105.9% | 0.00% | 0.0% |
| Q2 2022 | $364,000 | +15.6% | 25,894 | +17.9% | 0.00% | +33.3% |
| Q1 2022 | $315,000 | -19.2% | 21,969 | -23.2% | 0.00% | -25.0% |
| Q4 2021 | $390,000 | -34.8% | 28,588 | -21.7% | 0.00% | -33.3% |
| Q3 2021 | $598,000 | -3.5% | 36,528 | -0.9% | 0.01% | -14.3% |
| Q2 2021 | $620,000 | -10.1% | 36,858 | -2.5% | 0.01% | -22.2% |
| Q1 2021 | $690,000 | +198.7% | 37,784 | +196.8% | 0.01% | +200.0% |
| Q4 2020 | $231,000 | – | 12,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |